Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
From Service Provider to Strategic Partner
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability read more
Leveraging AI and ML to Optimize Drug Discovery – a CRO Perspective
CROs supporting early-stage drug discovery projects are establishing their own internal AI platforms to address their clients’ needs in an evolving field. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Transcenta Licenses Continuous Bioprocessing Technology to WuXi Biologics
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB ... read more
CordenPharma Invests $94M to Reach 500M Injectable Units Capacity
Thursday, September 10, 2026
CordenPharma plans to invest €80 million, or about $94 million, over multiple years to expand sterile injectable manufacturing at its Caponago site ... read more
Quva Acquires CAPS 503B Sterile Compounding Product Portfolio
Thursday, September 10, 2026
Quva Pharma has acquired a portfolio of sterile compounded medications from Central Admixture Pharmacy Services, or CAPS, after CAPS decided to exit ... read more
Summit Acquires Dallas Research Institute Through Pinnacle Network
Thursday, September 10, 2026
Summit Clinical Research Solutions has acquired Dallas Research Institute through its Pinnacle Clinical Research site network, expanding its clinical-... read more
Lonza Plans Oregon Spray-Drying Facility for Drug Development, Manufacturing
Thursday, September 10, 2026
Lonza plans to build a commercial-scale spray-drying facility at its Bend, Oregon, site, expanding its capacity to develop and manufacture spray-dried... read more